QTRX
NASDAQ
$3.90
Quanterix Corp (QTRX)
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advance precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the regions from Asia Pacific. The company is headquartered in Billerica, Massachusetts.
Sector:
Healthcare
Industry:
Medical Devices
Hold
Target: $4.33 (+11.10%)
Market Cap
$200M
P/B Ratio
0.71
Free Cash Flow Yield
-41.64%
Beta (5Y)
1.81
Price Chart
Valuation
Market Cap$200M
P/S1.29
P/B0.71
Profitability
Total Revenue (TTM)$145M
Gross Profit (TTM)$66M
EBITDA-$113M
Profit Margin-48.2%
Operating Margin-59.1%
EPS-$2.36
Financial Health
Free Cash Flow Yield-41.64%
Growth & Risk
EPS 5Y CAGR+15.06%
Revenue 5Y CAGR+13.74%
FCF 5Y CAGR+18.65%
Beta (5Y)1.81
Sharpe Ratio-0.10